Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|May 29, 2018
Ribociclib in premenopausal women with advanced breast cancerTheodoros Foukakis
European Journal of Cancer (Oxford, England : 1990)|April 22, 2026
Assessing the methodological quality of machine learning approaches in diagnostic accuracy meta-analyses: Insights from a recent study of 109 articlesPanagiotis Filis, Theodoros Foukakis
Lakartidningen|February 22, 2017
[Chemotherapy and targeted drugs to reinforce each other]Theodoros Foukakis, Jonas Bergh
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerTheodoros Foukakis, Claudette Falato, Jonas Bergh
Acta Oncologica (Stockholm, Sweden)|May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of conceptsAlexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute|April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysisAlexios Matikas, Theodoros Foukakis, Jonas Bergh
Molecular Oncology|March 9, 2023
The interplay between eosinophils and T cells in breast cancer immunotherapyIoannis Zerdes, Alexios Matikas, Theodoros Foukakis
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsTheodoros Foukakis, John Lövrot, Jonas Bergh
Expert Review of Anticancer Therapy|January 28, 2017
Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancerAlexios Matikas, Theodoros Foukakis, Ilias Michalakis, et al.
Eclinicalmedicine|November 3, 2025
Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort studyLouise Eriksson Bergman, Alexios Matikas, Xingrong Liu, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|May 29, 2018
Ribociclib in premenopausal women with advanced breast cancerTheodoros Foukakis
European Journal of Cancer (Oxford, England : 1990)|April 22, 2026
Assessing the methodological quality of machine learning approaches in diagnostic accuracy meta-analyses: Insights from a recent study of 109 articlesPanagiotis Filis, Theodoros Foukakis
Lakartidningen|February 22, 2017
[Chemotherapy and targeted drugs to reinforce each other]Theodoros Foukakis, Jonas Bergh
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerTheodoros Foukakis, Claudette Falato, Jonas Bergh
Acta Oncologica (Stockholm, Sweden)|May 25, 2017
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of conceptsAlexios Matikas, Theodoros Foukakis, Jonas Bergh
Journal of the National Cancer Institute|April 5, 2018
RE: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysisAlexios Matikas, Theodoros Foukakis, Jonas Bergh
Molecular Oncology|March 9, 2023
The interplay between eosinophils and T cells in breast cancer immunotherapyIoannis Zerdes, Alexios Matikas, Theodoros Foukakis
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsTheodoros Foukakis, John Lövrot, Jonas Bergh
Expert Review of Anticancer Therapy|January 28, 2017
Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancerAlexios Matikas, Theodoros Foukakis, Ilias Michalakis, et al.
Eclinicalmedicine|November 3, 2025
Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort studyLouise Eriksson Bergman, Alexios Matikas, Xingrong Liu, et al.
Pageof 13